News for:

 

Click the Chemical Profile link above for detailed information. Visit Betterchem's Drug Index for… Exclusivity Patents and market exclusivity Drug Information Prescribing and other information DMFs Type 2 drug master files Databases Free access to database search 21 CFR FDA regulations for this drug Federal Register FR search results for this drug Drug Recalls For Rx's using this API

FDA Approval Activities for this Drug… Sustiva (Efavirenz) Tablets & Capsules, 600 mg and 50, 100 & 200 mg respectively, Bristol-Myers Squibb NDA 20-972/S-18 & 21-360/S-3 6/10/03 7/8/03 7/8/03 Sustiva (Efavirenz) Tablets & Capsules, 600 mg and 50, 100 & 200 mg respectively, Bristol-Myers Squibb NDA 20-972/S-19 & 21-360/S-4 6/10/03 7/8/03 7/8/03 Sustiva (Efavirenz) Tablets & Capsules, 300 & 600 mg and 50, 100 & 200 mg respectively, Bristol-Myers Squibb NDA 20-972/S-17 & 21-360/S-1 9/20/02 9/27/02 Sustiva (Efavirenz) Tablets, 300 & 600 mg, Bristol-Myers Squibb Pharma Company NDA 21-360 2/1/02 2/27/02 2/4/02 5/15/02 Sustiva (efavirenz) Capsules, 50, 100 & 200 mg, Bristol-Myers Squibb Company NDA 20-972/S-016 1/29/03 2/12/03 2/13/03 Sustiva (efavirenz) Capsules, 50, 100 & 200 mg, DuPont Company NDA 20-972/S13 10/16/01 04/25/03 Sustiva (efavirenz), Bristol-Myers Squibb Company NDA 20-972/S-007 3/1/02 3/5/02 Sustiva (efavirenz), 50mg, 100mg, 200mg capsules (Group Leader Memo) (Divison Director Memo) DuPont Company NDA 20-972 9/17/98 9/24/98 9/17/98 12/10 Sustiva (efavirenz), 50 mg, 100 mg, and 200 mg capsules DuPont Company NDA 20-972/SE7-001 2/9/00 2/14/00 Sustiva Indication:For the treatment of HIV-1 infection Sustiva (Efavirenz) Capsules & Tablets, Bristol-Myers Squibb SUSTIVA (efavirenz) Capsules, Bristol-Myers Squibb, Efficacy Supplement with Clinical Data to Support SUSTIVA (efavirenz) Tablets, Bristol-Myers Squibb, Efficacy Supplement with Clinical Data to Support | Sustiva (efavirenz) tablets, GlaxoSmithKline, Labeling Revision | Sustiva (efavirenz) capsules, GlaxoSmithKline, Labeling Revision | SUSTIVA (efavirenz) Capsules, Bristol-Myers Squibb, Labeling Revision | SUSTIVA (efavirenz) Tablets, Bristol-Myers Squibb, Labeling Revision | Efavirenz Tablets, Aurobindo Pharma, Tentative Approval | Sustiva (efavirenz) capsules, Bristol-Myers Squibb, Labeling Revision | Sustiva (efavirenz) tablets, Bristol-Myers Squibb, Labeling Revision | Efavirenz Tablets, Cipla, Tentative Approval | Efavirenz Capsules, Aurobindo Pharma, Tentative Approval | Sustiva (efavirenz) Capsules, Bristol-Myers Squibb, Labeling Revision | Sustiva (efavirenz) Tablets, Bristol-Myers Squibb, Labeling Revision Visit Betterchem's Drug Index for FDA's latest approval information.   Find other drugs… A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | USActives.com | Pharma Job Search | Pharma Company News © 2011 FindingHealthOnline™